1 day Syros Pharmaceuticals (NASDAQ:SYRS) Rating Increased to Hold at StockNews.comMarketBeat
StockNews.com raised Syros Pharmaceuticals from a “sell” rating to a “hold” rating in a report on Tuesday.
XStockNews.com raised Syros Pharmaceuticals from a “sell” rating to a “hold” rating in a report on Tuesday.
X